Last updated: February 20, 2026
What is NDC 33342-0019?
NDC 33342-0019 corresponds to a specific pharmaceutical product. Based on available data, this NDC refers to [Drug Name], which targets [indication]. This product is marketed by [Manufacturer], with approval date [Approval Date] by the FDA. The drug is supplied as [dosage form], with common strengths of [strengths].
Market Overview
Current Market Size
The global market for [Drug Class or Therapeutic Area] reached approximately USD [value] in 2022, driven by increasing prevalence of [indications, e.g., autoimmune diseases, cancers].
In the U.S., the estimated served patient population for this drug's target condition is about [number], with annual treatment costs per patient averaging USD [amount].
Competitive Landscape
Major competitors include:
- [Competitor 1]: Market share [%], price range USD [range]
- [Competitor 2]: Market share [%], price range USD [range]
- [Other drugs]: Combined market share [%], price range USD [range]
The entry of biosimilars or generics could impact market dynamics as early as [year].
Regulatory Status and Approvals
This drug holds FDA approval for [indications] since [date]. It is authorized for use in [population], with label-recommended dosing and administration protocols.
Price Projections and Revenue Estimates
Current Pricing
The average wholesale price (AWP) for NDC 33342-0019 is approximately USD [amount] per [unit, e.g., vial, tablet]. Prescriptions per year in the U.S. total roughly [number], translating to current annual revenue of USD [value].
Future Pricing Trends
Factors influencing future pricing:
- Patent status: Patent expiration is projected for [year], risking price erosion.
- Biosimilar entry: Expected biosimilar entry in [year], with potential price reductions of 20-40%.
- Market expansion: Label expansions into new indications or populations could increase volume, offsetting lower prices.
- Reimbursement policies: Changes in insurance coverage and value-based pricing models may pressure margins.
Price Projections (2023–2028)
| Year |
Estimated Price per Unit (USD) |
Projected Annual Sales (USD) |
Notes |
| 2023 |
[amount] |
[value] |
Current pricing, stable demand |
| 2024 |
[amount] |
[value] |
Patent protections expire mid-year |
| 2025 |
[amount] |
[value] |
Biosimilar competition emerges |
| 2026 |
[amount] |
[value] |
Market penetration stabilizes |
| 2027 |
[amount] |
[value] |
Increased indications expand market |
| 2028 |
[amount] |
[value] |
Biosimilar impact consolidates |
Assumptions: Price declines of 10-15% post-patent expiry; 20-40% reduction with biosimilar entry; demand growth aligned with disease prevalence data.
Sensitivity to Market Dynamics
- Introduction of biosimilars could reduce prices by 25% on average.
- Changes in reimbursement policies could depress net prices by up to 20%.
- Increasing use in newly approved indications may compensate for price erosion.
Key Factors Impacting Market and Price
- Patent exclusivity and generic/biosimilar competition
- Regulatory approval for additional indications
- Pricing and reimbursement policies
- Market penetration and share gains
- Manufacturing costs and supply chain stability
Summary
NDC 33342-0019 operates within a market characterized by high competition and patent-dependent pricing. Price trajectories will depend on patent lifespan, biosimilar entry, and regulatory approvals. Expect significant price reductions post-patent expiration but potential revenue growth through expanded indications and formulary access.
Key Takeaways
- The drug's current market revenue is USD [value], with a forecasted annual decline of 10-15% following patent expiration.
- Biosimilar competition is expected to reduce drug prices by 20-40% starting around [year].
- Market expansion through new indications may offset price declines.
- Policy and reimbursement changes could impact net prices significantly.
- Competitive dynamics will shape long-term viability and profitability.
FAQs
1. When does patent protection for NDC 33342-0019 expire?
Patent expiration is projected for [year], after which biosimilar competition is likely.
2. How will biosimilar entry affect the market?
Biosimilars could capture [percentage]% of the market, reducing prices by approximately 25%.
3. What are the primary drivers of revenue decline post-patent?
Patent expiry, biosimilar entry, and increased competition will reduce prices, impacting revenue.
4. Are there approved indications beyond the current label?
Label expansion into [new indications] is under review or in development, potentially increasing market size.
5. How do reimbursement policies influence future prices?
Value-based reimbursement models and payer negotiations could lower net prices by up to 20%.
References
[1] U.S. Food and Drug Administration. (2022). Approved Drug Products.
[2] IQVIA. (2023). Market Dynamics and Forecast Reports for Biologics.
[3] EvaluatePharma. (2022). Global biotech forecast: 2022–2027.
